This provider averages 79 services per working day
Based on 197.9K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $46.8M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Averaging 79 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $505.04 | $225.66 | 2.24x | $279.38 | $3.9M | 17.2K | 14 |
| 2015 | $535.65 | $237.83 | 2.25x | $297.82 | $4.3M | 18.1K | 15 |
| 2016 | $526.47 | $231.58 | 2.27x | $294.89 | $4.3M | 18.4K | 15 |
| 2017 | $522.15 | $226.95 | 2.30x | $295.20 | $4.4M | 19.5K | 13 |
| 2018 | $523.52 | $227.89 | 2.30x | $295.63 | $4.7M | 20.7K | 12 |
| 2019 | $528.18 | $222.30 | 2.38x | $305.88 | $4.8M | 21.5K | 15 |
| 2020 | $553.10 | $226.23 | 2.44x | $326.87 | $4.9M | 21.6K | 11 |
| 2021 | $574.49 | $232.11 | 2.48x | $342.38 | $4.7M | 20.4K | 13 |
| 2022 | $737.88 | $292.39 | 2.52x | $445.49 | $5.2M | 17.7K | 14 |
| 2023 | $987.63 | $248.97 | 3.97x | $738.66 | $5.7M | 22.8K | 18 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | 79.1K | $22.3M | $281.67 | 2.13x |
| J0178 | Injection, aflibercept, 1 mg | 23.6K | $17.2M | $731.04 | 2.42x |
| 67028 | Injection of drug into eye | 25.4K | $2.3M | $91.83 | 5.48x |
| 92014 | Established patient complete exam of visual system | 14.4K | $1.3M | $91.57 | 2.58x |
| 92134 | Imaging of retina | 31.4K | $983.8K | $31.30 | 4.65x |
| J3490 | Unclassified drugs | 237 | $433.1K | $1.8K | 3.90x |
| J3590 | Unclassified biologics | 184 | $363.5K | $2.0K | 3.81x |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1.6K | $361.4K | $219.29 | 3.86x |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 3.0K | $359.3K | $120.36 | 3.75x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 3.2K | $244.5K | $77.14 | 3.75x |
| 92012 | Established patient problem focused exam of visual system | 3.9K | $233.6K | $60.30 | 2.00x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 1.5K | $180.9K | $118.64 | 2.63x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 4.0K | $115.3K | $28.67 | 3.92x |
| 92250 | Photography of the retina | 2.6K | $102.5K | $40.09 | 3.96x |
| J9035 | Injection, bevacizumab, 10 mg | 1.8K | $98.8K | $55.19 | 4.80x |
| 92004 | New patient complete exam of visual system | 579 | $61.5K | $106.16 | 2.74x |
| J7999 | Compounded drug, not otherwise classified | 678 | $45.8K | $67.49 | 4.59x |
| 67042 | Removal of membrane from the retina, pars plana approach | 29 | $27.9K | $960.44 | 5.17x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 41 | $23.4K | $571.06 | 5.05x |
| 67145 | Photocoagulation treatment to prevent detachment of retina | 64 | $19.5K | $304.89 | 3.56x |
This provider submits charges 2.55 times higher than what Medicare actually pays.
A markup ratio of 2.55x means for every $100 Medicare pays, this provider initially charges $255. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Jason Ysasaga, M.D. | Amarillo, TX | $61.5M | ✓ Clear |
| Harshivinderjit Bains, MD | Tyler, TX | $53.9M | ✓ Clear |
| Ryan Rush, MD | Amarillo, TX | $53.6M | ✓ Clear |
| Tien Wong, M.D. | Houston, TX | $51.2M | ✓ Clear |
| Thomas Bochow, M.D., M.P.H. | Tyler, TX | $49.4M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data